Velocity BioGroup, LLC
Pat Trifunov has a diverse work experience spanning several industries and roles. In 1987, they began working at GlaxoSmithKline as the Vice President of Medicare, CMS, and Federal Sales until 2008. Following this, they joined Velocity BioGroup, LLC in 2008 as the President & CEO. In 2009, they also served on the Board of Directors at SkyQuest Technology Consulting Private Limited until 2014.
Pat Trifunov holds a B.S. Pharm degree in Pharmacy from the University of Saskatchewan.
This person is not in any teams
Velocity BioGroup, LLC
If the government pays, the feds usually have a role in it. What that means for you is that laws and regulations, centralized decision-making and cost-driven access constraints all play a critical role in market access. We know our way around Federal Markets to ensure that you will too. Velocity BioGroup is a strategic group of long-time business executives in the pharmaceutical, biologics, medical devices and Federal Markets, with very high-level relationships in the commercial and government payer world, public relations and advocacy communities. The primary function of the Velocity BioGroup team is to support your organization in framing a compelling formula for the success of your key products introduced in the market.